Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-12

FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation, resulting in an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEREZYME (imiglucerase)

Snippet

SUPPL AP for CEREZYME (IMIGLUCERASE)